Histologic transformation in lung cancer: when one door shuts, another opens

被引：10

作者：

Sato, Yuki ^{[2
]}

Saito, Go ^{[3
]}

Fujimoto, Daichi ^{[1
]}

机构：

[1] Wakayama Med Univ, Internal Med 3, 811-1 Kimiidera, Wakayama 6418509, Japan

[2] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[3] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan

来源：

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2022年 / 14卷

关键词：

EGFR; histologic transformations; lineage plasticity; non-small-cell lung cancer; small-cell lung cancer; SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE INHIBITORS; ALK-REARRANGED ADENOCARCINOMA; NONSMALL CELL; ACQUIRED-RESISTANCE; PROSTATE-CANCER; NEUROENDOCRINE CARCINOMA; SOMATIC INACTIVATION; RETINOBLASTOMA GENE; GENOMIC ANALYSIS;

D O I：

10.1177/17588359221130503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histologic transformation (HT) is a major cause of drug resistance to therapy in patients with lung cancer. HTs to small-cell lung cancer (SCLC) have been reported frequently in patients with epidermal growth factor receptor (EGFR)-mutated lung cancer. Although HTs have an impact on the clinical outcomes in patients owing to a high refractoriness to treatments, there is limited data on the prevalence, causes, mechanisms, treatment efficacy, and future treatment strategies. In this review, we assess the literature regarding HTs comprehensively, including those describing EGFR-tyrosine kinase inhibitors, other molecular targeted drugs, and immune checkpoint inhibitors. Furthermore, we discuss the mechanisms of HTs and the lineage plasticity to SCLC and squamous cell carcinoma in lung cancer. In addition, we summarize the treatment efficacy and future perspectives of HTs in patients with lung cancer, and propose better management strategies for this group of patients.

引用

页数：18

共 138 条

[1] MIXED SMALL-CELL AND NON-SMALL CELL LUNG-CANCER [J].

ADELSTEIN, DJ ;

TOMASHEFSKI, JF ;

SNOW, NJ ;

HORRIGAN, TP ;

HINES, JD .

CHEST, 1986, 89 (05) :699-704

[2] Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study [J].

Aggarwal, Rahul ;

Huang, Jiaoti ;

Alumkal, Joshi J. ;

Zhang, Li ;

Feng, Felix Y. ;

Thomas, George V. ;

Weinstein, Alana S. ;

Friedl, Verena ;

Zhang, Can ;

Witte, Owen N. ;

Lloyd, Paul ;

Gleave, Martin ;

Evans, Christopher P. ;

Youngren, Jack ;

Beer, Tomasz M. ;

Rettig, Matthew ;

Wong, Christopher K. ;

True, Lawrence ;

Foye, Adam ;

Playdle, Denise ;

Ryan, Charles J. ;

Lara, Primo ;

Chi, Kim N. ;

Uzunangelov, Vlado ;

Sokolov, Artem ;

Newton, Yulia ;

Beltran, Himisha ;

Demichelis, Francesca ;

Rubin, Mark A. ;

Stuart, Joshua M. ;

Small, Eric J. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) :2492-+

[3] The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer [J].

Akamatsu, Shusuke ;

Wyatt, Alexander W. ;

Lin, Dong ;

Lysakowski, Summer ;

Zhang, Fan ;

Kim, Soojin ;

Tse, Charan ;

Wang, Kendric ;

Mo, Fan ;

Haegert, Anne ;

Brahmbhatt, Sonal ;

Bell, Robert ;

Adomat, Hans ;

Kawai, Yoshihisa ;

Xue, Hui ;

Dong, Xin ;

Fazli, Ladan ;

Tsai, Harrison ;

Lotan, Tamara L. ;

Kossai, Myriam ;

Mosquera, Juan Miguel ;

Rubin, Mark A. ;

Beltran, Himisha ;

Zoubeidi, Amina ;

Wang, Yuzhuo ;

Gleave, Martin E. ;

Collins, Colin C. .

CELL REPORTS, 2015, 12 (06) :922-936

[4] Signatures of mutational processes in human cancer [J].

Alexandrov, Ludmil B. ;

Nik-Zainal, Serena ;

Wedge, David C. ;

Aparicio, Samuel A. J. R. ;

Behjati, Sam ;

Biankin, Andrew V. ;

Bignell, Graham R. ;

Bolli, Niccolo ;

Borg, Ake ;

Borresen-Dale, Anne-Lise ;

Boyault, Sandrine ;

Burkhardt, Birgit ;

Butler, Adam P. ;

Caldas, Carlos ;

Davies, Helen R. ;

Desmedt, Christine ;

Eils, Roland ;

Eyfjord, Jorunn Erla ;

Foekens, John A. ;

Greaves, Mel ;

Hosoda, Fumie ;

Hutter, Barbara ;

Ilicic, Tomislav ;

Imbeaud, Sandrine ;

Imielinsk, Marcin ;

Jaeger, Natalie ;

Jones, David T. W. ;

Jones, David ;

Knappskog, Stian ;

Kool, Marcel ;

Lakhani, Sunil R. ;

Lopez-Otin, Carlos ;

Martin, Sancha ;

Munshi, Nikhil C. ;

Nakamura, Hiromi ;

Northcott, Paul A. ;

Pajic, Marina ;

Papaemmanuil, Elli ;

Paradiso, Angelo ;

Pearson, John V. ;

Puente, Xose S. ;

Raine, Keiran ;

Ramakrishna, Manasa ;

Richardson, Andrea L. ;

Richter, Julia ;

Rosenstiel, Philip ;

Schlesner, Matthias ;

Schumacher, Ton N. ;

Span, Paul N. ;

Teague, Jon W. .

NATURE, 2013, 500 (7463) :415-+

[5] Acquired Resistance to KRASG12C Inhibition in Cancer [J].

Awad, M. M. ;

Liu, S. ;

Rybkin, I. I. ;

Arbour, K. C. ;

Dilly, J. ;

Zhu, V. W. ;

Johnson, M. L. ;

Heist, R. S. ;

Patil, T. ;

Riely, G. J. ;

Jacobson, J. O. ;

Yang, X. ;

Persky, N. S. ;

Root, D. E. ;

Lowder, K. E. ;

Feng, H. ;

Zhang, S. S. ;

Haigis, K. M. ;

Hung, Y. P. ;

Sholl, L. M. ;

Wolpin, B. M. ;

Wiese, J. ;

Christiansen, J. ;

Lee, J. ;

Schrock, A. B. ;

Lim, L. P. ;

Garg, K. ;

Li, M. ;

Engstrom, L. D. ;

Waters, L. ;

Lawson, J. D. ;

Olson, P. ;

Lito, P. ;

Ou, S. -H. I. ;

Christensen, J. G. ;

Janne, P. A. ;

Aguirre, A. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) :2382-2393

[6] Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer [J].

Bai, Wenwen ;

Zhen, Chanjun ;

Zhang, Ruohui ;

Yu, Wenhui ;

Zhou, Zhiguo .

TRANSLATIONAL CANCER RESEARCH, 2021, 10 (08) :3694-3704

[7]

Ball M., 2022, COLD SPRING HARB MOL, V8

[8] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer [J].

Bar, Jair ;

Ofek, Efrat ;

Barshack, Iris ;

Gottfried, Teodor ;

Zadok, Oranit ;

Kamer, Iris ;

Urban, Damien ;

Perelman, Marina ;

Onn, Amir .

LUNG CANCER, 2019, 138 :109-115

[9] The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer [J].

Bishop, Jennifer L. ;

Thaper, Daksh ;

Vahid, Sepideh ;

Davies, Alastair ;

Ketola, Kirsi ;

Kuruma, Hidetoshi ;

Jama, Randy ;

Nip, Ka Mun ;

Angeles, Arkhjamil ;

Johnson, Fraser ;

Wyatt, Alexander W. ;

Fazli, Ladan ;

Gleave, Martin E. ;

Lin, Dong ;

Rubin, Mark A. ;

Collins, Colin C. ;

Wang, Yuzhuo ;

Beltran, Himisha ;

Zoubeidi, Amina .

CANCER DISCOVERY, 2017, 7 (01) :54-71

[10] Combining DNA damaging therapeutics with immunotherapy: more haste, less speed [J].

Brown, Jessica S. ;

Sundar, Raghav ;

Lopez, Juanita .

BRITISH JOURNAL OF CANCER, 2018, 118 (03) :312-324

← 1 2 3 4 5 6 7 8 9 10 →